Format

Send to

Choose Destination
J Immunol Methods. 2014 Aug;410:3-17. doi: 10.1016/j.jim.2014.02.011. Epub 2014 Mar 4.

Generation of improved humanized mouse models for human infectious diseases.

Author information

1
The University of Massachusetts Medical School, 368 Plantation Street, Worcester, MA 01605, United States. Electronic address: michael.brehm@umassmed.edu.
2
The Jackson Laboratory, 600 Main Street, Bar Harbor, ME 04609, United States. Electronic address: michael.wiles@jax.org.
3
The University of Massachusetts Medical School, 368 Plantation Street, Worcester, MA 01605, United States. Electronic address: dale.greiner@umassmed.edu.
4
The Jackson Laboratory, 600 Main Street, Bar Harbor, ME 04609, United States. Electronic address: lenny.shultz@jax.org.

Abstract

The study of human-specific infectious agents has been hindered by the lack of optimal small animal models. More recently development of novel strains of immunodeficient mice has begun to provide the opportunity to utilize small animal models for the study of many human-specific infectious agents. The introduction of a targeted mutation in the IL2 receptor common gamma chain gene (IL2rg(null)) in mice already deficient in T and B cells led to a breakthrough in the ability to engraft hematopoietic stem cells, as well as functional human lymphoid cells and tissues, effectively creating human immune systems in immunodeficient mice. These humanized mice are becoming increasingly important as pre-clinical models for the study of human immunodeficiency virus-1 (HIV-1) and other human-specific infectious agents. However, there remain a number of opportunities to further improve humanized mouse models for the study of human-specific infectious agents. This is being done by the implementation of innovative technologies, which collectively will accelerate the development of new models of genetically modified mice, including; i) modifications of the host to reduce innate immunity, which impedes human cell engraftment; ii) genetic modification to provide human-specific growth factors and cytokines required for optimal human cell growth and function; iii) and new cell and tissue engraftment protocols. The development of "next generation" humanized mouse models continues to provide exciting opportunities for the establishment of robust small animal models to study the pathogenesis of human-specific infectious agents, as well as for testing the efficacy of therapeutic agents and experimental vaccines.

KEYWORDS:

Animal model; Humanized mice; Immune response; Immunodeficient mouse; Infectious agents; NSG

PMID:
24607601
PMCID:
PMC4155027
DOI:
10.1016/j.jim.2014.02.011
[Indexed for MEDLINE]
Free PMC Article

Supplemental Content

Full text links

Icon for Elsevier Science Icon for PubMed Central
Loading ...
Support Center